RGC · Regencell Bioscience Holdings Ltd · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-27 | LO WILLIAM WING YAN DR |
Director |
Other↓
Filing footnotes — Stock option (right to purchase) (Direct)
The exercise price has given effect to the share split(s) of the Issuer since the date of grant of the option. On May 27, 2026, the Issuer repurchased from the Reporting Person options to purchase 70,600 ordinary shares of the Issuer at a price of $15.00 per option. The aggregate consideration payable to the Reporting Person under the Option Repurchase Agreement is further reduced by the aggregate exercise price of the repurchased options. |
Stock option (right to purchase)
|
70,600 |
| 2026-05-27 | HUI EVANA YEE WAH |
Director |
Other↓
Filing footnotes — Stock option (right to purchase) (Direct)
The exercise price has given effect to the share split(s) of the Issuer since the date of grant of the option. On May 27, 2026, the Issuer repurchased from the Reporting Person options to purchase 19,000 ordinary shares of the Issuer at a price of $15.00 per option. The aggregate consideration payable to the Reporting Person under the Option Repurchase Agreement is further reduced by the aggregate exercise price of the repurchased options. |
Stock option (right to purchase)
|
19,000 |